SYROS PHARMACEUTICALS INC (SYRS) Stock News

NASDAQ:SYRS - Nasdaq - US87184Q2066 - Common Stock - Currency: USD

0.1172 -0.01 (-8.44%)

After market: 0.1072 -0.01 (-8.53%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

SYRS Latest News, Press Relases and Analysis

All

Press Releases

3 months ago - By: Rege Nephro CO., Ltd.

Rege Nephro Acquires Tamibarotene-Related Assets from Syros Pharmaceuticals for U.S. Clinical Trials

4 months ago - By: Benzinga - Mentions: RGC TNXP SRPT JAGX ...

12 Health Care Stocks Moving In Tuesday's Intraday Session

4 months ago - By: Benzinga - Mentions: HMR ANTE ATXI AGMH ...

Dow Dips Over 200 Points; US Industrial Production Increases More than Expected